Analytical Method Validation: An ICH Q2(R2) Guide

Analytical method validation is the process of demonstrating, with documented experimental evidence, that an analytical procedure is suitable for its intended purpose. The internationally recognized framework is ICH Q2(R2), revised in 2023 alongside the new ICH Q14 guideline on analytical procedure development. This article explains each validation characteristic in practical terms and what “validated method” should mean when you see it on a certificate of analysis.

What analytical method validation is, and is not

Validation answers a narrow question: does this procedure, run as written, produce results that are reliable enough for this specific use? A reversed-phase HPLC method validated for purity of one peptide is not automatically valid for a different sequence, a different sample concentration or a different detection wavelength.

Validation also does not replace routine controls. Each run still needs system suitability checks and appropriate standards. Validation shows the procedure can work; system suitability shows it is working on the day.

ICH Q2(R2) frames validation as one stage in a procedure’s lifecycle. ICH Q14 covers how a procedure is developed and how knowledge from development, such as robustness studies, supports the validation that follows.

The ICH Q2(R2) validation characteristics

Specificity and selectivity

Specificity is the ability to assess the analyte unequivocally in the presence of components that may be expected to be present, such as impurities, degradants, counter-ions and matrix. For an HPLC purity method this is typically shown by:

• resolving known related substances, such as deletion sequences or oxidized forms, from the main peak;
• stress (forced degradation) studies with acid, base, oxidation, heat or light to generate likely degradants;
• peak purity assessment with a diode-array detector or mass spectrometry.

Where one technique cannot be fully specific, Q2(R2) allows a combination of procedures to achieve the necessary selectivity.

Range, response and linearity

The range is the interval between the lowest and highest levels for which the procedure has suitable accuracy, precision and response. Q2(R2) groups linearity under “response”, recognizing that some techniques have non-linear but well-characterized calibration models.

For a linear response, evaluation commonly includes a plot of signal against concentration, the correlation coefficient, the y-intercept, the slope and a residual plot. ICH Q2 has historically recommended a minimum of five concentrations. Typical ranges include 80%–120% of the test concentration for an assay, and from the reporting threshold to 120% of the specification for an impurity test.

Accuracy

Accuracy is the closeness of the result to an accepted reference value. It is usually shown by analyzing a reference material or by spiking known amounts of analyte, with results expressed as percent of the known amount. A common design is nine determinations across three concentration levels covering the range.

Precision

Precision describes the scatter of results from repeated measurements, expressed as standard deviation or relative standard deviation (RSD). It has three levels:

1. Repeatability: same analyst, equipment and short time interval; for example, six determinations at 100% of the test concentration.
2. Intermediate precision: variation within one laboratory across days, analysts or instruments.
3. Reproducibility: variation between laboratories, relevant for method transfer or collaborative studies.

Detection limit and quantitation limit

The detection limit (LOD) is the lowest amount that can be detected but not necessarily quantified; the quantitation limit (LOQ) is the lowest amount that can be quantified with acceptable accuracy and precision. Common approaches include a signal-to-noise ratio of about 3:1 for LOD and 10:1 for LOQ, or calculation from the standard deviation of the response (σ) and the calibration slope (S): LOD = 3.3σ/S and LOQ = 10σ/S.

Robustness

Robustness is the capacity of a procedure to remain unaffected by small, deliberate variations in parameters, such as column temperature, mobile-phase pH, gradient slope or flow rate. Under Q2(R2) and Q14, robustness is ideally evaluated during development, and its findings inform the system suitability criteria and operating ranges written into the method.

Which characteristics apply to which test

Not every test needs every characteristic. The table reflects the general approach in ICH Q2(R2).

Characteristic	Identification	Impurities: quantitative	Impurities: limit test	Assay / content
Specificity / selectivity	Yes	Yes	Yes	Yes
Range (response, linearity)	No	Yes	No	Yes
Accuracy	No	Yes	No	Yes
Precision (repeatability, intermediate)	No	Yes	No	Yes
Detection limit	No	Not usually	Yes	No
Quantitation limit	No	Yes	No	No

For a peptide, an MS identity test mainly needs specificity, while HPLC purity is handled as a quantitative impurity test. USP <1225> uses a similar structure, grouping procedures into categories I–IV.

Validated, verified or qualified: reading the COA

These words are often used loosely. In quality-system usage they have distinct meanings:

• Validated: the laboratory has run a planned study against predefined acceptance criteria and documented the results in a validation report.
• Verified: a compendial procedure, already validated by the pharmacopeia, has been shown to work under actual conditions of use in the laboratory, as described in USP <1226>.
• Qualified or fit-for-purpose: the method has been evaluated to a lesser or differently scoped extent, which is common in research settings. This is not a defect, but the scope should be stated.

Questions worth asking

1. Which method was used, and is it identified by a number or version?
2. Was it validated for this analyte, or for a class of similar materials?
3. What is the reported LOQ for impurities, and what range was demonstrated?
4. Which laboratory performed the test, and were system suitability criteria met for the run?

Our articles on HPLC purity testing and HPLC system suitability cover the day-to-day controls that sit alongside validation. For an overview of how Veridryx approaches documentation, see our quality standards page.

Common gaps in validation packages

• Specificity shown only with a clean standard, without impurities or stressed samples.
• A correlation coefficient reported without residuals, hiding curvature at the ends of the range.
• Range not covering the actual reporting threshold for impurities.
• Precision data from a single day, presented as intermediate precision.
• Method changes after validation without an assessment of whether revalidation is needed.

Each of these can make a “validated” label less informative than it appears, and each is easy to check if the summary report is available.

Frequently asked questions

What changed from ICH Q2(R1) to Q2(R2)?

Q2(R2) broadened the scope to include multivariate and non-linear procedures, reorganized linearity under response within range, and linked validation to development knowledge described in the companion guideline ICH Q14.

Is an r value of 0.999 required for linearity?

ICH Q2(R2) does not set a fixed correlation coefficient. Acceptance criteria are defined by the laboratory for the intended use, and residual plots are generally more informative than r alone.

Does a validated method ensure every result is correct?

No. It shows the procedure is capable of reliable results; each run still depends on system suitability, correct standards, sample preparation and trained analysts.

When does a method need revalidation?

Typically after changes that could affect performance, such as a new sample matrix, different equipment principles or altered critical parameters. The extent of revalidation depends on a documented assessment of the change.

References

1. ICH Q2(R2) Validation of Analytical Procedures.
2. ICH Q14 Analytical Procedure Development.
3. USP General Chapter <1225> Validation of Compendial Procedures.
4. USP General Chapter <1226> Verification of Compendial Procedures.